SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-014242
Filing Date
2023-05-12
Accepted
2023-05-12 16:24:01
Documents
91
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clnn20230331_10q.htm   iXBRL 10-Q 1360612
2 EXHIBIT 31.1 ex_500632.htm EX-31.1 12745
3 EXHIBIT 31.2 ex_500633.htm EX-31.2 12510
4 EXHIBIT 32.1 ex_500634.htm EX-32.1 6163
5 EXHIBIT 32.2 ex_500635.htm EX-32.2 6226
11 img.jpg GRAPHIC 83423
  Complete submission text file 0001437749-23-014242.txt   8632918

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA clnn-20230331.xsd EX-101.SCH 89909
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clnn-20230331_cal.xml EX-101.CAL 57727
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20230331_def.xml EX-101.DEF 572961
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20230331_lab.xml EX-101.LAB 523552
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20230331_pre.xml EX-101.PRE 611571
85 EXTRACTED XBRL INSTANCE DOCUMENT clnn20230331_10q_htm.xml XML 1327494
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39834 | Film No.: 23916175
SIC: 2834 Pharmaceutical Preparations